Company profile
Dynacure company profile
Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases.The Dynacure team leverages its proven track record in rare disease drug development to build a pipeline of novel drugs. Dynacure is developing DYN101, an investigational antisense medicine designed to modulate the expression of dynamin 2 for the treatment of Centronuclear Myopathies, with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders.
Business identity
- Website
- https://www.dynacure.com/
- Contact email
- [email protected]
- Operating status
- Closed
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 2016-01-01
Headquarters
- Headquarters
- Illkirch-Graffenstaden, Grand Est, France
- Postal code
- 67412
- Country code
- FR
- Continent
- Europe